Download 306-15-FOI finalresponse1

Ein cyf / Our ref:
Dyddiad / Date:
306/15/FOI
11th December 2015
You asked us:
1. Within your health trust how many unique patients with Non-small-cell lung carcinoma
[Stage IIIB/Stage IV] have been treated in the past 6 months?
2. Of those patients please split by their current drug treatment;
Afatinib (Giotrif)
Ceritinib (Zykadia)
Crizotinib (Xalkori)
Erlotinib (Tarceva)
Gefitinib (Iressa)
Nitendaninb + docetaxel
Pemetrexed (Alimta)
Gemcitabine mono or in combination with carboplatin / cisplatin
Paclitaxel mono or in combination with carboplatin / cisplatin
Doxetaxel mono or in combination with carboplatin / cisplatin
Vinorelbine [or other Vinka alkaloid] mono or in combination with carboplatin / cisplatin
Other
3. Does your trust carry out EGFR [Epidermal Growth Factor Receptor] tests in house or
in a named reference centre?
4. Within your trust how many unique patients with Advanced Prostate Cancer have been
treated in the past 6 months?
5. How many patients with Advanced Prostate Cancer have received ;
Abiraterone (Zytiga)
Cabazitaxel (Jevtana)
Docetaxel (Taxotere)
Enzalutamide (Xtandi)
Radium-223 (Xofigo)
If your trust is unable to identify patients by the condition and treatment, please supply all
patients for treatment, regardless of condition.
Our Response:
1. Within the past 6 months 32 patients were diagnosed with lung cancer stage IIIB/IV
and received chemotherapy.
2. Provided in the table below is the split of drugs.
Cyfeiriad Gohebiaeth ar gyfer y Cadeirydd a'r Prif Weithredwr / Correspondence address for Chairman and Chief Executive:
Swyddfa'r Gweithredwyr / Executives’ Office,
Ysbyty Gwynedd, Penrhosgarnedd
Bangor, Gwynedd LL57 2PW
Gwefan: www.pbc.cymru.nhs.uk / Web: www.bcu.wales.nhs.uk
Drug
Afatinib (Giotrif)
Ceritinib (Zykadia)
Crizotinib (Xalkori)
Erlotinib (Tarceva)
Gefitinib (Iressa)
Nitendaninb + docetaxel
Pemetrexed (Alimta)
Gemcitabine mono or in combination with carboplatin /
cisplatin
Paclitaxel mono or in combination with carboplatin /
cisplatin
Doxetaxel mono or in combination with carboplatin /
cisplatin
Vinorelbine [or other Vinka alkaloid] mono or in
combination with carboplatin / cisplatin
Other
Number of patients
1
0
0
12
4
0
*
*
*
*
*
-
* These drugs are not prescribed specifically for this diagnosis, therefore we are unable
to extract numbers of patients prescribed for the cancers you refer to in your request.
3. Epidermal Growth Factor Receptor (EGFR) tests are carried out internally within the
Health Board.
4. Please note that the system used to collate data (Canisc), does not differentiate
between prostate and advanced prostate cancer, therefore we are unable to provide a
response to your request.
5. The following table provides a breakdown of the number of patients receiving the
requested drugs in the specified time period. However, please note that these drugs
may not be prescribed for advanced prostate cancer.
Drug
Abiraterone (Zytiga)
Cabazitaxel (Jevtana)
Docetaxel (Taxotere)
Enzalutamide (Xtandi)
Radium-223 (Xofigo)
7
0
*
14
0
* Unfortunately we are unable to quantify this data as docetaxel can be used for other
indications